Anastrozole is typically prescribed for postmenopausal women who have hormone receptor-positive breast cancer. It can be used as a first-line treatment for early breast cancer, as well as for advanced or metastatic breast cancer. Pre-menopausal women are generally not given anastrozole as their primary treatment because their ovaries still produce significant amounts of estrogen, which can diminish the drug's effectiveness.
